Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 |  | Patent: 3 | ||
2 | | Patent: 1 | ||
3 | | Coronavirus disease 2019 (COVID-19) | Patent: 1 | |
4 |  | Health care,Drug,Levocetirizine hydrochloride, ...[+2] | Patent: 1 | |
5 | | Biotechnology,Agriculture,Fishery, ...[+2] | Patent: 1 |
Top 5 New Entrants companies in Pantoprazole Sodium
by Most Patent Filing In 3 Years in the China in 2020
The Pantoprazole Sodium top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 3 Years Pantoprazole Sodium New Entrants in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
The sodium salt form of a substituted benzimidazole with proton pump inhibitor activity. Pantoprazole is a lipophilic, weak base that crosses the parietal cell membrane and enters the acidic parietal cell canaliculus where it becomes protonated, producing the active metabolite sulfenamide, which forms an irreversible covalent bond with two sites of the H+/K+-ATPase enzyme located on the gastric parietal cell, thereby inhibiting both basal and stimulated gastric acid production.
Page generation time:
May 04 2025